# Hui‐Chuan Sun

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hui-chuan-sun/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,501 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 76 |
| i10-index | 243 |
| Last Known Institution | Jilin University |
| OpenAlex ID | https://openalex.org/A5017352295 |
| ORCID iD | https://orcid.org/0000-0003-3761-7058 |
| Works | 513 |

## Researcher papers

- [Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma](https://scholariq.org/papers/single-cell-landscape-of-the-ecosystem-in-early-relapse-hepatocellular-carcinoma/)
- [Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-hepatocellular-carcinoma-2019/)
- [Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)](https://scholariq.org/papers/guidelines-for-diagnosis-and-treatment-of-primary-liver-cancer-in-china-2017/)
- [Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial](https://scholariq.org/papers/atezolizumab-plus-bevacizumab-versus-active-surveillance-in-patients-with/)
- [Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-primary-liver-cancer-2022-edition/)
- [Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study](https://scholariq.org/papers/adjuvant-transarterial-chemoembolization-for-hbv-related-hepatocellular/)
- [Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study](https://scholariq.org/papers/neoadjuvant-three-dimensional-conformal-radiotherapy-for-resectable/)
- [Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma](https://scholariq.org/papers/dissecting-spatial-heterogeneity-and-the-immune-evasion-mechanism-of-ctcs-by/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)

## Researcher university

- [Jilin University](https://scholariq.org/institutions/jilin-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.